Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dihydroxyacetone serum for aluminum phosphide poisoning
IRCT20150606022569N4Phase 2Completed
- Sponsor
- North Khorasan University of Medical Sciences
- Start
- Nov 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of Dihydroxyacetone in Aluminium phosphide poisoning, sponsored by North Khorasan University of Medical Sciences. Primary endpoints: Change in blood pressure, Change in electrocardiogram and 1 more. Started Nov 2023; status: completed.
02
Drugs
Dihydroxyacetone
03
Conditions
Aluminium phosphide poisoning
Beyond the preview
Go deeper on IRCT20150606022569N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20150606022569N4.